Adaptive Biotechnologies Corp (NAS:ADPT)
$ 3.65 0.21 (6.1%) Market Cap: 537.89 Mil Enterprise Value: 294.57 Mil PE Ratio: 0 PB Ratio: 1.95 GF Score: 72/100

Adaptive Biotechnologies Corp at Bank of America Healthcare Conference Transcript

May 11, 2022 / 03:40PM GMT
Release Date Price: $6.5 (-10.17%)
Derik De Bruin
BofA Securities, Research Division - MD of Equity Research

Everyone, welcome to the 2022 Bank of America Healthcare Conference live from Las Vegas. I'm Derik De Bruin, the senior life sciences and diagnostics tools analyst here for Bank of America. And with us this morning is Adaptive Biotechnologies. Chad Robins, Chief Executive Officer, Co-Founder and Chairman, is here for the company.

Chad, thanks for being here. Thanks for making the trip down from Seattle...

Chad M. Robins
Adaptive Biotechnologies Corporation - Co-Founder, CEO & Chairman

Thanks for having me.

Derik De Bruin
BofA Securities, Research Division - MD of Equity Research

To here. A little bit different -- when I was flying in on Sunday, my plane was delayed because there was a massive dust storm blowing through, so Seattle a little bit different than Las Vegas in that sense.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot